EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKohortenstudieOpen Access · CC BY 4.0

A Mediation Analysis of Obesity and Adiponectin Association with Postmenopausal Breast Cancer Risk: A Nested Cohort Study in the International Breast Cancer Intervention Study II (IBIS-II) Prevention Trial

Debora Macis iD, Federica Bellerba iD, Valentina Aristarco iD, Harriet Johansson iD, Aliana Guerrieri-Gonzaga iD, Matteo Lazzeroni iD, Ivana Sestak, Jack Cuzick, Andrea DeCensi iD, Bernardo Bonanni iD, Sara Gandini iD

Nutrients · 2024

DOI: 10.3390/nu16132098 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2024. Verfasst von Debora Macis und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Prevention and Genetics, European Institute of Oncology (IEO), Scientific Institute for Research, Hospitalization and Healthcare (…. Hauptthemen laut MEDLINE: Adiponectin, Breast Neoplasms, Postmenopause, Obesity. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute, the Italian Ministry of Health with Ricerca Finalizzata, Ricerca Corrente, and 5 × 1000 funds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity is a risk factor for postmenopausal breast cancer (BC), and evidence suggests a role for adiponectin in the relationship between obesity and BC. We investigated whether adiponectin or other biomarkers mediate the effect of body mass index (BMI) on postmenopausal BC risk in a cohort study nested in the IBIS-II Prevention Trial. We measured adiponectin, leptin, IGF-I, IGFBP-1, high-sensitivity C-reactive protein, glycemia, insulin, HOMA-IR index, and SHBG in baseline and 12-month serum samples from 123 cases and 302 matched controls in the placebo arm of the IBIS-II Prevention trial. We conducted the main mediation analysis considering baseline BMI as an exposure and the 12-month adiponectin increase as a mediator after adjustment for the Tyrer–Cuzick score and the lipid-lowering medications/supplements use. In the multivariable Cox model, both the 12-month adiponectin increase (HR, 0.60; 95%CI, 0.36–1.00) and BMI were associated with BC risk (HR, 1.05; 95%CI, 1.00–1.09), with a 40% reduction in women with a 12-month increase in adiponectin. A significantly higher cumulative hazard of BC events was observed in obese women (BMI > 30) with decreased adiponectin (p = 0.0087). No mediating effect of the adiponectin increase on the total effect of BMI on BC risk was observed (natural indirect effect: HR, 1.00; 95%CI, 0.98–1.02). Raising adiponectin levels might be an attractive target for postmenopausal BC prevention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdiponectinBreast NeoplasmsPostmenopauseObesityBody Mass IndexHumansFemaleMiddle AgedRisk FactorsCohort StudiesAgedLeptinBiomarkersProportional Hazards ModelsInsulin-Like Growth Factor I

Stichwörter der Autor:innen

BMIadiponectinbreast cancer preventionbreast cancer riskmediation analysis

Substanzen

AdiponectinLeptinBiomarkersADIPOQ protein, humanInsulin-Like Growth Factor I

Autor:innen und Institutionen

  • Division of Cancer Prevention and Genetics, European Institute of Oncology (IEO), Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), 20141 Milan, Italy.
  • Molecular and Pharmaco-Epidemiology Unit, Department of Experimental Oncology, European Institute of Oncology (IEO), Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), 20139 Milan, Italy.
  • Wolfson Institute of Population Health, Queen Mary University of London, London EC1M 6BQ, UK.
  • Division of Medical Oncology, Ente Ospedaliero Galliera, 16128 Genoa, Italy.

ORCID-Profile: Debora Macis, Federica Bellerba, Valentina Aristarco, Harriet Johansson, Aliana Guerrieri-Gonzaga, Matteo Lazzeroni, Andrea DeCensi, Bernardo Bonanni, Sara Gandini

Förderung

  • Ministero della Salute
  • the Italian Ministry of Health with Ricerca Finalizzata
  • Ricerca Corrente, and 5 × 1000 funds
  • the IBIS-II study from Cancer Research UK
  • the Breast Cancer Research Foundation, and AstraZeneca

Zitieren

APA

Macis, D., Bellerba, F., Aristarco, V., Johansson, H., Guerrieri-Gonzaga, A., Lazzeroni, M., Sestak, I., Cuzick, J., DeCensi, A., Bonanni, B., & Gandini, S. (2024). A Mediation Analysis of Obesity and Adiponectin Association with Postmenopausal Breast Cancer Risk: A Nested Cohort Study in the International Breast Cancer Intervention Study II (IBIS-II) Prevention Trial. Nutrients. https://doi.org/10.3390/nu16132098

Vancouver

Macis D, Bellerba F, Aristarco V, Johansson H, Guerrieri-Gonzaga A, Lazzeroni M, et al. A Mediation Analysis of Obesity and Adiponectin Association with Postmenopausal Breast Cancer Risk: A Nested Cohort Study in the International Breast Cancer Intervention Study II (IBIS-II) Prevention Trial. Nutrients. 2024. doi:10.3390/nu16132098

BibTeX
@article{Macis2024,
  author = {Macis, Debora and Bellerba, Federica and Aristarco, Valentina and Johansson, Harriet and Guerrieri-Gonzaga, Aliana and Lazzeroni, Matteo and Sestak, Ivana and Cuzick, Jack and DeCensi, Andrea and Bonanni, Bernardo and Gandini, Sara},
  title = {A Mediation Analysis of Obesity and Adiponectin Association with Postmenopausal Breast Cancer Risk: A Nested Cohort Study in the International Breast Cancer Intervention Study II (IBIS-II) Prevention Trial},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16132098}
}
Kostenlos starten →